Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Hematological Oncology|February 15, 2022
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in EuropeMark Bishton, Scott Marshall, Jatinder Harchowal, et al.British Journal of Haematology|August 12, 2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaMichael Dickinson, David Ritchie, Daniel J DeAngelo, et al.Leukemia & Lymphoma|April 4, 2019
Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphomaMarc Sorigue, Mark Bishton, Eva Domingo-Domenech, et al.Journal of Hematology & Oncology|October 31, 2021
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO studyMichael Wang, Radhakrishnan Ramchandren, Robert Chen, et al.BMC Cancer|March 26, 2024
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trialGraham McIlroy, Siân Lax, Charlotte Gaskell, et al.British Journal of Haematology|December 15, 2018
Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysisNicolás Martínez-Calle, Sarah Hartley, Matthew Ahearne, et al.British Journal of Haematology|September 19, 2022
Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013-2019Hanhua Liu, Charles A Stiller, Colin J Crooks, et al.British Journal of Haematology|June 22, 2019
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicityToby A Eyre, Amy A Kirkwood, Julia Wolf, et al.British Journal of Haematology|October 31, 2023
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United KingdomAdrian Minson, Nada Hamad, Pietro Di Ciaccio, et al.Cancer Research|May 28, 2016
The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho SignalingMariam Mansour, Sue Haupt, Ai-Leen Chan, et al.Pageof 4